Send to

Choose Destination
Transplant Proc. 2011 Jul-Aug;43(6):2457-8. doi: 10.1016/j.transproceed.2011.06.016.

Epidemiology and outcome of hepatitis C relapse in transplant recipients.

Author information

Dipartimento di Medicina Interna, Università Tor Vergata, Hepatology Unit, Fondazione PoliclinÍco Tor Vergata, Rome, Italy.


Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center